23.08.18: Conference Call
Conference CallLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 17, 2018 Category: Pharmaceuticals Source Type: news
17.08.18: Bayer rejects WirtschaftsWoche report on Dicamba lawsuits
Bayer rejects WirtschaftsWoche report on Dicamba lawsuitsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 17, 2018 Category: Pharmaceuticals Source Type: news
16.08.18: Following completion of the divestment of Crop Science businesses to BASF
Bayer: Conditions for beginning Monsanto integration fulfilledLegal remedies against jury verdict in California announcedmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 16, 2018 Category: Pharmaceuticals Source Type: news
01.08.18: Not intended for U.S. and UK Media
Bayer receives approval of new treatment regimen for Eylea® in the EUNew treatment regimen could offer patients with neovascular age-related macular degeneration (AMD) extended proactive dosing already in the first year, while delivering strong visual gains / Data from ALTAIR study demonstrate sustainability of new approach in 57% of patients who extended their treatment interval to 12 weeks or moremehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 1, 2018 Category: Pharmaceuticals Source Type: news
31.07.18: LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer's prescription dermatology unit
LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer's prescription dermatology unitSignificant step to bolster LEO Pharma's role as a leading global dermatology company with its goal of helping 125 million patients by 2025mehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 31, 2018 Category: Pharmaceuticals Source Type: news
